Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee Sustainable Technologies Inc. (Dundee Technologies), Dundee Resources Limited, and Goodman & Company, Investment Counsel Inc. The Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. Through the development of its patented processes, the GlassLock Process and the CLEVR Process, Dundee Technologies extracts precious and base metals from ores and concentrates, while stabilizing contaminants such as arsenic.


TSX:DC.A - Post by User

Comment by pierrelebelon Nov 30, 2022 3:38pm
197 Views
Post# 35140829

RE:TauRx Press Release

RE:TauRx Press Release

TauRx will announce further data on completion of the 24-month study in mid-2023, with additional blood-based biomarker data commissioned to be available early next year. Meanwhile, TauRx is preparing for regulatory submissions primarily in the UK, US, and Canada, with other key territories on their target list, including China, to follow alongside additional studies.

The recent announcement of additional investment of USD119 million through a warrants exercise triggered by the study results allows the company to move forward with regulatory submissions and preparation for market availability.

<< Previous
Bullboard Posts
Next >>